Hormone-Refractory Prostate Cancer
Also known as: Hormone Refractory Prostate Cancer Disease / Hormone Refractory Prostate Cancer / Castration-resistant prostate cancer / Hormone refractory prostate cancer (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB00445 | Epirubicin | An anthracycline topoisomerase II inhibitor used as an adjuvant to treating axillary node metastases in patients who have undergone surgical resection of primary breast cancer. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB00445 | Epirubicin | DNA topoisomerase 2-alpha | target |
DB00445 | Epirubicin | DNA | target |
DB00445 | Epirubicin | Multidrug resistance-associated protein 1 | transporter |
DB00445 | Epirubicin | UDP-glucuronosyltransferase 2B7 | enzyme |
DB00445 | Epirubicin | Cytosolic phospholipase A2 | enzyme |